Hans J. W. de Haard
Corporate Officer/Principal en University of Utrecht .
Perfil
Hans J. W. de Haard fundó argenx SE y AgomAb Therapeutics NV. En la actualidad, ocupa el cargo de Director Científico de argenx SE. También es profesor en la Universit de Franche-Comt y profesor de inmunología de camélidos en la Universidad de Utrecht. Anteriormente fue científico en Unilever NV y director de desarrollo tecnológico en Ablynx NV. El Dr. De Haard se doctoró y se licenció en la Universidad de Maastricht.
Cargos activos de Hans J. W. de Haard
Empresas | Cargo | Inicio |
---|---|---|
University of Utrecht | Corporate Officer/Principal | - |
Université de Franche-Comté | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Hans J. W. de Haard.
Empresas | Cargo | Fin |
---|---|---|
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Founder | - |
ARGENX SE | Founder | - |
UNILEVER N.V. | Chief Tech/Sci/R&D Officer | - |
ABLYNX | Chief Tech/Sci/R&D Officer | - |
Formación de Hans J. W. de Haard.
Maastricht University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ARGENX SE | Health Technology |
Empresas privadas | 3 |
---|---|
Unilever NV
Unilever NV Food DistributorsDistribution Services Unilever NV engages in the production and marketing of consumer goods in the nutrition, hygiene, and personal care categories. It operates through the following segments: Beauty and Personal Care, Foods and Refreshment, and Home Care. The Beauty and Personal Care segment covers the sales of skin and hair care products, deodorants and oral care products. The Foods and Refreshment segment includes the sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads. The Home Care segment is in charge of the sales of home care products such as powders, liquids and capsules, soap bars, and a wide range of cleaning products. The company was founded on November 9, 1927 and is headquartered in Rotterdam, Netherlands. | Distribution Services |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
- Bolsa de valores
- Insiders
- Hans J. W. de Haard